111 (YI) Director Chen Yang Luke Sells $11K of Stock
Chen Yang Luke trimmed a holding in 111, Inc. on June 12, 2026, following a series of recent share purchases.
Reviewed by automated data checks against the source filing. How we make and check alerts
Chen Yang Luke, Director at 111, Inc. ($YI), sold 49,920 shares at an average price of $0.23, worth about $11,481.60, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $YI is down 24.3% after 1 week, down 22.3% after 1 month and down 36.0% to date (from the $4.89 close on Jun 12, 2026).
YI
111, Inc.
Key Points
- Insider Chen Yang Luke sold 49,920 shares of 111, Inc. (NasdaqGM: YI) on June 12, 2026, for a total value of $11,481.60.
- The stock traded around $4.57 on Tuesday, resting between its 52-week low of $2.48 and high of $11.17 with a forward P/E ratio of 26.04.
- The recent transaction follows several acquisitions by Chen and fellow insider Sun Jian David earlier in May 2026.
Get $YI trade alerts by text
We text you when insiders, Congress or big funds trade $YI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated 111, Inc. alert may contain errors. Disclosures
Chen Yang Luke Sells 111, Inc. Shares
Insider Chen Yang Luke recently parted with 49,920 shares of 111, Inc. (NasdaqGM: YI) on June 12, 2026. The transaction totaled $11,481.60, with the shares changing hands at $0.23 each. Insider trades of this nature are filed regularly with the Securities and Exchange Commission to keep the public informed of executive and major holder activities.
Inside the Recent Insider Transactions
The June sale marks a shift for Chen Yang Luke, who had previously been adding to a stake in the healthcare platform. Back on May 11, 2026, Chen picked up 54,759 shares before following up with another 413,168 shares on May 12, 2026. Prior to that, Chen acquired 126,295 shares on September 8, 2023. Fellow insider Sun Jian David has also been active in the stock, picking up 378,737 shares on May 11, 2026, and an additional 413,168 shares on May 12, 2026, building on an earlier purchase of 18,366 shares made back on September 12, 2018.
Stock Performance and Valuation Context
Shares of 111, Inc. changed hands at $4.57 on Tuesday. The medical distribution company carries a market cap of $32.1 million and holds a forward P/E ratio of 26.04 based on expected earnings. Over the past year, the equity has seen a low of $2.48 alongside a high of $11.17. Its 50-day moving average rests at $3.64, while the 200-day moving average sits higher at $5.09.
Understanding 111, Inc. Operations
Headquartered in Shanghai, China, 111, Inc. operates an integrated digital and traditional network within the healthcare sector. The business focuses on connecting supply chains for drug makers while providing patient education, digital promotion tools, and direct wholesale and retail online pharmacy options. Through its various online platforms and marketplaces, the firm distributes prescription medicines, nutritional supplements, and medical devices to pharmacies and individual buyers alike.
What to Watch Next for YI
Market participants tracking 111, Inc. will look toward upcoming corporate updates and future Form 4 disclosures to monitor insider sentiment. Because insider transactions can stem from diverse personal financial strategies, they form just one part of a broader picture for the Nasdaq-listed firm.
Related Filing Alerts
Source: Chen Yang Luke's Form 4 filing on $YI (Jun 12, 2026). Find the original filing: YI Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts